mittyri
★★  

Russia,
2014-03-08 16:24
(4492 d 22:51 ago)

Posting: # 12580
Views: 5,154
 

 ODT vs. IR [Regulatives / Guidelines]

Dear All,

could you you help me with EMA guideline understanding at this part:

"If the ODT test product is an extension to another oral formulation, a 3-period study is recommended in order to evaluate administration of the orodispersible tablet both with and without concomitant fluid intake. However, if bioequivalence between ODT taken without water and reference formulation with water is demonstrated in a 2-period study, bioequivalence of ODT taken with water can be assumed."

What does it mean?
"We recommend you to perform 3-period study. By the way you can perform simple 2-period study and it's enough"

Who will perform complex 3-period study in the presence of simple solution?:confused:

Kind regards,
Mittyri
jag009
★★★

NJ,
2014-03-10 20:01
(4490 d 19:14 ago)

@ mittyri
Posting: # 12586
Views: 4,525
 

 ODT vs. IR

Hi,

❝ What does it mean?

❝ "We recommend you to perform 3-period study. By the way you can perform simple 2-period study and it's enough"



It does look strange. It seems like the paragraph that you quoted is a generalization. To me it seems like the actual recommendations are listed in the next 2 paragraphs.

John
Dr_Dan
★★  

Germany,
2014-03-10 20:36
(4490 d 18:39 ago)

@ mittyri
Posting: # 12587
Views: 4,475
 

 ODT vs. IR

Dear mittyri
You are right, this inconsistency is confusing. But you will find something similar also in the guideline for MR products (draft). On the one hand the EMA would like to see a study to assess the food effect (MR) or the effect of water (your case) and on the other hand EMA commits that this effect doesn't matter as long as you are bioequivalent in a simple 2 way cross over (or two 2 way for MR). My suggestion is to conduct the simple study and to discuss arguments which led to the refusal of the 3 way study in modul 2.5 Clinical Overview of the dossier.
I hope this helps
Dr_Dan

Kind regards and have a nice day
Dr_Dan
mittyri
★★  

Russia,
2014-03-14 11:05
(4487 d 04:11 ago)

@ Dr_Dan
Posting: # 12621
Views: 4,386
 

 ODT vs. IR

Thank you, John and Dr_Dan!
You've dispelled my doubts :cool:

Kind regards,
Mittyri
fno
☆    
Homepage
Belgium,
2014-03-14 15:51
(4486 d 23:25 ago)

@ mittyri
Posting: # 12628
Views: 4,542
 

 ODT vs. IR

❝ However, if bioequivalence between ODT taken without water and reference formulation with water is demonstrated in a 2-period study, bioequivalence of ODT taken with water can be assumed."


What about such a situation:
- ODT without water (w-) and IR with water (w+) have indeed the same bioavailability, as mentioned in the guidance:
(1) FODT|w- / FIR|w+ = 1
- Taking ODT with water results in a biovailability decreased by 30%:
(2) FODT|w+ / FODT|w- = 0.7
- Then, the bioavailability of ODT with water relative to IR with water is:
FODT|w+ / FIR|w+ = (1) x (2) = 0.7
=> ODT with water can certainly NOT be assumed bioequivalent to IR with water :confused:

The assumption (2) above does not seem unrealistic, as the rationale for developing an ODT alternative to an existing oral formulation could be to improve the bioavailability by increasing its absorption by the buccal mucosa and then limiting some acidic degradation in the stomach or a strong 1st-pass effect.

So, either I miss completely the point somewhere, or the guidance actually does not care about BE with water... even if it tries to convince us of the opposite :-P ???

Kind regards,
Fabrice
Dr_Dan
★★  

Germany,
2014-03-17 11:30
(4484 d 03:46 ago)

@ fno
Posting: # 12635
Views: 4,349
 

 ODT vs. IR

Dear fno
If taking ODT with water results in a biovailability decreased by 30% compared to taking ODT without water then this would imply that a high portion of bioavailability (i.e. 30%) is caused by absorption within the oral cavity. In this case it would be highly unlikely that ODT without water and IR with water have the same bioavailability.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan
fno
☆    
Homepage
Belgium,
2014-03-17 13:18
(4484 d 01:58 ago)

@ Dr_Dan
Posting: # 12636
Views: 4,428
 

 ODT vs. IR

Dear Dr_Dan,

This was only to emphasize that the guideline statement does not mathematically hold. Now, I fully agree that the physiological or pharmacological relevance is another story.

This again illustrates the ambiguity of this part of the guidance:
  • either one does not care about the effect of water on ODT bioavailabilityn and then the paragraph quoted by Mittyri should read
    "If the ODT test product is an extension to another oral formulation and bioequivalence between ODT taken without water and reference formulation with water is demonstrated in a 2-period study, bioequivalence of ODT taken with water can be assumed."
  • or the water effect on ODT is deemed as possibly relevant and then the paragraph should read
    "If the ODT test product is an extension to another oral formulation, a 3-period study is recommended in order to evaluate administration of the orodispersible tablet both with and without concomitant fluid intake."
... but not something in-between as currently written.

Kind regards,
Fabrice
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
373 visitors (0 registered, 373 guests [including 22 identified bots]).
Forum time: 16:16 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5